首页 | 本学科首页   官方微博 | 高级检索  
     

新型免疫调节剂--来氟米特
引用本文:王荣耕,刘承平,王清海. 新型免疫调节剂--来氟米特[J]. 精细与专用化学品, 2004, 12(23): 10-11
作者姓名:王荣耕  刘承平  王清海
作者单位:河北科技大学理学院,河北,石家庄,050018;山东淄博金城实业(集团)股份有限公司化工厂,山东,淄博,255100;石家庄三九利鑫制药有限公司,河北,石家庄,050024
摘    要:简要介绍了新型免疫调节剂来氟米特--N-(4-三氟甲基苯基)-5-甲基异噁唑-4-甲酰胺的结构和性质;同时对合成来氟米特的中间体5-甲基异噁唑-4-甲酰氯和对三氟甲基苯胺的合成路线进行了概述.通过近年某些国家对来氟米特副作用的论证,分析了可能对来氟米特的应用市场造成一定的影响,进而影响其中间体5-甲基异噁唑-4-甲酰氯和对三氟甲基苯胺的市场.

关 键 词:来氟米特  免疫调节剂  5-甲基异噁唑-4-甲酰氯  三氟甲基苯胺
修稿时间:2004-10-25

A Novel Immune Regulator:Leflunomide
WANG Rong-geng,LIU Cheng-ping,WANG Qing-hai. A Novel Immune Regulator:Leflunomide[J]. Fine and Specialty Chemicals, 2004, 12(23): 10-11
Authors:WANG Rong-geng  LIU Cheng-ping  WANG Qing-hai
Affiliation:WANG Rong-geng1,LIU Cheng-ping2,WANG Qing-hai3
Abstract:The structure and properties of novel immune regulator leflunomide, N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-formamide, were introduced. Meanwhile, the different routs for synthesizing intermediates: 5-methylisoxazole-4-formyl chloride and trifluoromethyl aniline were summarized. Through the demonstration on side-effect of leflunomide made by some countries recently, the probable impact to application market of leflunomide and to its intermediates could be given.
Keywords:leflunomide  immune regulator  5-methylisoxazole-4-formyl chloride  trifluoromethyl aminobenzene
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号